Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4798434
Max Phase: Preclinical
Molecular Formula: C11H11N3OS2
Molecular Weight: 265.36
Molecule Type: Unknown
Associated Items:
ID: ALA4798434
Max Phase: Preclinical
Molecular Formula: C11H11N3OS2
Molecular Weight: 265.36
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CNc1nc(C)c(C(=O)/C=C/c2nccs2)s1
Standard InChI: InChI=1S/C11H11N3OS2/c1-7-10(17-11(12-2)14-7)8(15)3-4-9-13-5-6-16-9/h3-6H,1-2H3,(H,12,14)/b4-3+
Standard InChI Key: ICDHBBVYWKBVLG-ONEGZZNKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 265.36 | Molecular Weight (Monoisotopic): 265.0344 | AlogP: 2.85 | #Rotatable Bonds: 4 |
Polar Surface Area: 54.88 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 2.82 | CX LogP: 1.85 | CX LogD: 1.85 |
Aromatic Rings: 2 | Heavy Atoms: 17 | QED Weighted: 0.68 | Np Likeness Score: -2.04 |
1. Sanachai, Kamonpan, Aiebchun, Thitinan, Mahalapbutr, Panupong, Seetaha, Supaphorn, Tabtimmai, Lueacha, Maitarad, Phornphimon, Xenikakis, Iakovos, Geronikaki, Athina, Choowongkomon, Kiattawee, Rungrotmongkol, Thanyada. (2021) Discovery of novel JAK2 and EGFR inhibitors from a series of thiazole-based chalcone derivatives, 12 (3.0): [PMID:34046625] [10.1039/d0md00436g] |
Source(1):